Skip to main content

COVID-19's Damage to Organs Can Harm Heart, Too

Medically reviewed by Judith Stewart, BPharm. Last updated on March 21, 2024.

By Dennis Thompson HealthDay Reporter

THURSDAY, March 21, 2024 -- COVID-19 can damage a person’s heart even if the coronavirus doesn’t directly infect the heart tissue, a new study has found.

The severe inflammation that COVID causes in other organs, like the lungs, appears to indirectly cause heart damage associated with the infection, researchers report.

“After a COVID infection, the immune system can inflict remote damage on other organs by triggering serious inflammation throughout the body – and this is in addition to damage the virus itself has directly inflicted on the lung tissue,” senior author Dr. Matthais Nahrendorf, a professor of radiology at Harvard Medical School, said in a news release.

For the study, researchers analyzed heart tissue samples taken from 21 patients who died with COVID-related lung failure. These samples were compared to specimens from 33 patients who died from causes unrelated to COVID.

The research team specifically focused on immune cells called cardiac macrophages. These cells normally help keep heart tissue healthy by sustaining metabolism and clearing out harmful bacteria, but can cause harmful inflammation in response to a heart attack or heart failure.

Researchers found that COVID infection increased the total number of cardiac macrophages in human heart tissue, and caused them to shift from their normal routine and become inflammatory.

This inflammation can weaken the heart, Nahrendorf said

A mouse study confirmed what researchers found in human tissue samples. Mice infected with COVID had immune responses strong enough to cause the same heart macrophage shift from helpful to harmful, researchers said.

“These findings can also be applied more generally, as our results suggest that any severe infection can send shockwaves through the whole body,” Nahrendorf said.

The research team also found that blocking the immune response in mice with an antibody treatment stopped the flow of inflammatory cardiac macrophages and prevented heart damage.

This suggests that “suppressing the inflammation through treatments might help minimize these complications,” researcher Michelle Olive, associate director of the Basic and Early Translational Research Program at the National Heart, Lung, and Blood Institute, said in a news release.

However, preventive measures to help COVID patients avoid heart damage need to be tested in humans, Nahrendorf said.

The new study appears in the journal Circulation.

Sources

  • National Heart, Lung, and Blood Institute, news release, March 20, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted March 2024

Further Support and Information on COVID-19

Read this next

Extended Course of Paxlovid Adds No Benefit for Those With Long COVID

FRIDAY, June 7, 2024 -- An extended course of the antiviral drug Paxlovid won’t ease a person’s Long COVID symptoms, a new study finds. People who took Paxlovid for...

FDA Panel OKs New COVID Vaccine for Fall

THURSDAY, June 6, 2024 -- A U.S. Food and Drug Administration advisory panel on Wednesday recommended updating the formula for COVID vaccines ahead of a fall campaign that will...

Long COVID's Toll Outlined in New Report

THURSDAY, June 6, 2024 -- Long COVID continues to plague millions of Americans as the health costs of the pandemic linger four years later, a new report warns. In a hefty...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.